Physician profile

Amit Koduri

Humble, TX

NPI 1164165742

$17,910.33

in general payments reported to CMS, 2019-2025

5 companies · $392 in 2025

The $392 reported for 2025 was more than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$15,000.00
Food and Beverage$1,396.63
Travel and Lodging$1,139.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $17,518.18 2022-2024 Emblem Mri S-Icd, Watchman Flx, Lux-Dx Insertable Cardiac Monitor
Bridgebio Pharma, INC. $204.61 2025 Attruby
Abiomed $143.66 2025
Lantheus Medical Imaging, INC. $26.47 2025 Definity
Ethicon US, LLC $17.41 2025 Stratafix, Surgicel Nu-Knit, Dermabond

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amit Koduri

$17,910.33

in general payments reported 2019-2025

Years
2022-2025
Top company
Boston Scientific Corporation
Context
The $392 reported for 2025 was more than what a typical provider received nationally.

https://glasscript.com/doctor/11426595/amit-koduri

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.